ABO incompatible renal transplantation: A paradigm ready for broad implementation

Transplantation

Volumn 87, Issue 8, 2009, Pages 1246-1255

  Montgomery, Robert A ^a,d   Locke, Jayme E ^a   King, Karen E ^a   Segev, Dorry L ^a   Warren, Daniel S ^a   Kraus, Edward S ^a   Cooper, Matthew ^b   Simpkins, Christopher E ^a   Singer, Andrew L ^a   Stewart, Zoe A ^a   Melancon, J Keith ^a   Ratner, Lloyd ^c   Zachary, Andrea A ^a   Haas, Mark ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d Departments of Pediatrics Medicine Oncology and Radiation Oncology   (United States)

Author keywords

ABO incompatible; Antibody mediated rejection; Kidney transplantation

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; HEMAGGLUTININ; IMMUNOGLOBULIN;

ADULT; AGED; ANTIBODY MEDIATED REJECTION; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL PROTOCOL; CREATININE CLEARANCE; FEMALE; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; SPLENECTOMY; B LYMPHOCYTE; BIOLOGICAL MODEL; BLOOD GROUP ABO SYSTEM; BLOOD GROUP INCOMPATIBILITY; GRAFT REJECTION; HISTOCOMPATIBILITY; IMMUNOLOGY; METABOLISM; MORTALITY; ORGAN TRANSPLANTATION; PHYSIOLOGY; STATISTICS; SURVIVOR;

ABO BLOOD-GROUP SYSTEM; B-LYMPHOCYTES; BLOOD GROUP INCOMPATIBILITY; GRAFT REJECTION; GRAFT SURVIVAL; HEMAGGLUTININS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY TRANSPLANTATION; MODELS, BIOLOGICAL; ORGAN TRANSPLANTATION; PLASMAPHERESIS; SURVIVORS; TRANSPLANTATION IMMUNOLOGY;

EID: 65549126350     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31819f2024     Document Type: Article

References (35)

1. Alexandre GP, Squifflet JP, De Bruyere M, et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987; 19: 4538.
2. Tanabe K, Takahashi K, Sonda K, et al. Long-term results of ABOincompatible living kidney transplantation:Asingle-center experience. Transplantation 1998; 65: 224.
3. HumeDM,Merrill JP, MillerBF,et al. Experienceswithrenalhomotransplantation in the human: Report of nine cases. J Clin Invest 1955; 34: 327.
4. Starzl TE, Marchioro TL, Holmes JH, et al. Renal homografts in patients with major donor-recipient blood group incompatibilities. Surgery 1964; 55: 195.
5. Segev DL, Gentry SE, Warren DS, et al. Kidney paired donation and optimizing the use of live donor organs. JAMA 2005; 293: 1883.
6. Segev DL, Simpkins CE, Warren DS, et al. ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant 2005; 5: 2570.
7. Technical Manual-American Association of Blood Banks, [ed. 14]. Bethesda, AABB 2002.
8. Lucas DP, Paparounis ML, Myers L, et al. Detection of HLA class I-specific antibodies by the QuikScreen enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 1997; 4: 252.
9. Zachary AA, Ratner LE, Graziani JA, et al. Characterization of HLA class I specific antibodies by ELISA using solubilized antigen targets. II. Clinical relevance. Hum Immunol 2001; 62: 236.
10. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
11. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria-An addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708.
12. Montgomery RA, Cooper M, Kraus E, et al. Renal transplantation at the Johns Hopkins Comprehensive Transplant Center. Clin Transpl 2003:199.
13. Montgomery RA, Zachary AA. Transplanting patients with a positive donor-specific crossmatch:Asingle center's perspective. Pediatr Transplant 2004; 8: 535.
14. Shepherd JC, Subramanian A, Montgomery RA, et al. West Nile virus encephalitis in a kidney transplant recipient.AmJ Transplant 2004; 4: 830.
15. Sonnenday CJ, Warren DS, Cooper M, et al. Plasmapheresis,CMVhyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 2004; 4: 1315.
16. Tyden G, Kumlien G, Fehrman I. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation 2003; 76: 730.
17. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725.
18. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605.
19. Gentry SE, Segev DL, Montgomery RA. A comparison of populations served by kidney paired donation and list paired donation. Am J Transplant 2005; 5: 1914.
20. Segev DL, Kucirka LM, Gentry SE, et al. Utilization and outcomes of kidney paired donation in the United States. Transplantation 2008; 86: 502.
21. Takahashi K, Tanabe K, Ooba S, et al. Prophylactic use of a new immunosuppressive agent, deoxyspergualin, in patients with kidney transplantation from ABO-incompatible or preformed antibody-positive donors. Transplant Proc 1991; 23(1 Pt 2): 1078.
22. Takahasi K, Ota K, Ooba S, et al. Use of a novel immunosuppressive agent, deoxyspergualin, in a case of ABO-incompatible kidney transplantation. Clin Transpl 1989:306.
23. Genberg H, Kumlien G, Wennberg L, et al. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: A 3-year follow-up. Transplantation 2008; 85: 1745.
24. Ishida H, Miyamoto N, Shirakawa H, et al. Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation- Single center analysis. Am J Transplant 2007; 7: 825.
25. Takahashi K, Saito K, Takahara S, et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004; 4: 1089.
26. Gloor J, Stegall M. ABO-incompatible kidney transplantation with and without splenectomy. Transplantation 2006; 82: 720.
27. Haas M, Rahman MH, Racusen LC, et al. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings. Am J Transplant 2006; 6: 1829.
28. Haas M, Segev DL, Racusen LC, et al. C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. J Am Soc Nephrol 2009; 20: 197.
29. Gloor JM, Cosio FG, Rea DJ, et al. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant 2006; 6: 1841.
30. Kee TY, Chapman JR, O'Connell PJ, et al. Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants. Transplantation 2006; 82: 36.
31. Nankivell BJ, Borrows RJ, Fung CL, et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326.
32. Mengel M, Chapman JR, Cosio FG, et al. Protocol biopsies in renal transplantation: Insights into patient management and pathogenesis. Am J Transplant 2007; 7: 512.
33. Haas M, Segev DL, Racusen LC, et al. Arteriosclerosis in kidneys from healthy live donors: Comparison of wedge and needle core perioperative biopsies. Arch Pathol Lab Med 2008; 132: 37.
34. Locke JE, Zachary AA, Haas M, et al. The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection. Am J Transplant 2007; 7: 842.
35. Kaplan B, Gangemi A, Thielke J, et al. Successful rescue of refractory, severe antibody mediated rejection with splenectomy. Transplantation 2007; 83: 99.